Babesia Testing: Why False Negatives Can Delay Treatment

Babesia testing has important limitations
A test may miss low-level infection or a Babesia species it was not designed to detect
Clinical history, geography, and the type of test all matter

She came to my office exhausted after six months of fevers, sweats, and crushing fatigue. Her initial testing for Babesia was negative. It wasn’t confirmed until much later, after PCR and antibody testing were positive. But by then, treatment was delayed, and her recovery was harder.

False-negative Babesia testing can be one reason patients with Lyme disease and possible coinfections remain sick. Ordering a test that is poorly suited to the stage of illness, relying on a single method, testing when parasite levels are very low, or testing only for certain Babesia species can produce negative results despite continued clinical concern.

I see this problem in my practice. Some patients with symptoms suggestive of Babesia have been told, “Your test was negative, so you don’t have Babesia.” Yet testing may have been incomplete, performed later in the illness, limited by low parasite levels, or directed at a species that did not adequately address the patient’s geographic exposure.

What Is Babesia?

Babesia is a parasite that infects red blood cells, somewhat like the parasites that cause malaria. In the United States, Babesia microti is the predominant cause of human babesiosis and is transmitted primarily by blacklegged ticks.

Common symptoms of babesiosis can include:

1. Fever and sweats
2. Chills
3. Profound fatigue and weakness
4. Headache or muscle aches
5. Anemia in more significant infections

In my practice, some patients also describe drenching night sweats and a sensation of difficulty getting a satisfying breath, often called “air hunger.” These symptoms are not specific for Babesia and should be interpreted in the context of the entire clinical picture.

Babesia may occur along with Lyme disease because the infections can be transmitted by the same blacklegged tick. Coinfection can complicate diagnosis because symptoms may overlap and the infections require different treatments.⁴

Why Babesia Can Become Harder to Detect

During acute babesiosis, parasites may be visible inside red blood cells on a peripheral blood smear. Laboratory abnormalities can include hemolytic anemia, thrombocytopenia, elevated bilirubin, and elevated lactate dehydrogenase (LDH).

But parasite levels are not necessarily constant throughout the course of infection.

A prospective study by Krause and colleagues found that Babesia microti DNA could remain detectable after acute infection, including in people who had few or no symptoms. Among untreated subjects without specific symptoms, babesial DNA persisted for a mean of 82 days. One participant experienced recrudescent disease two years later.³

This matters because microscopy becomes more difficult when only a small proportion of red blood cells are infected.

Can Babesia Persist at Very Low Levels?

Yes. Published research has documented persistent, intermittent, or low-level Babesia infection.

A 2024 review by Chen and colleagues focused specifically on persistent and relapsing human babesiosis with low-grade parasitemia. The authors found that these cases have been reported in both immunocompromised and immunocompetent patients.¹

Asymptomatic infection may sometimes persist for months or longer. Earlier studies reviewed by the authors also documented prolonged low-level parasitemia and occasional relapse.¹

Persistent or relapsing babesiosis is particularly important in people whose immune systems have difficulty clearing the parasite. Reported risk factors include the absence of a spleen, malignancy, B-cell lymphoma, HIV/AIDS, chemotherapy, and treatment with B-cell-depleting medications such as rituximab.^1,7

The practical lesson is not that every patient with persistent symptoms has ongoing babesiosis. Rather, documented low-grade parasitemia demonstrates why Babesia may sometimes become difficult to detect and why a single negative test must be interpreted in the context of the patient’s symptoms, exposure, immune status, and stage of illness.

Can a Babesia Test Miss the Infection Because It Tests for the Wrong Species?

Potentially, yes. Babesiosis is caused by several Babesia species, and laboratory assays do not necessarily detect every species equally well.

This is particularly important when PCR testing is species-specific. A PCR assay detects genetic sequences selected by the laboratory. If an assay is designed specifically for Babesia microti, for example, a negative result does not necessarily answer whether another Babesia species is present.

Cook and Puri highlighted this issue in a 2024 review examining evidence for babesiosis in the United Kingdom. They noted that Babesia species associated with human infection vary geographically and that testing strategies focused on particular species may fail to identify infections involving other species.⁸

The authors discussed several species relevant to human disease in Europe, including B. divergens, B. microti, and B. venatorum. They also cited a human infection in France involving a B. crassa-like organism that was initially negative using routine PCR assays directed at B. divergens and B. microti.⁸

This does not mean that every negative Babesia test represents an undetected species. It means that clinicians need to understand exactly what a particular assay detects before deciding what a negative result excludes.

Why Geography Matters When Testing for Babesia

Where a patient lives and where that person has traveled can be relevant when selecting and interpreting Babesia testing.

Babesia microti accounts for most recognized human babesiosis in the United States, particularly in the Northeast and upper Midwest. Other Babesia organisms have also been associated with human infection in North America and elsewhere.^6,7

The species encountered in Europe are not necessarily identical to those most commonly encountered in the United States. A patient’s residence, travel history, tick exposure, transfusion history, and the species targeted by the laboratory therefore can all affect how much confidence should be placed in a negative result.

This is an important distinction: a negative test for one Babesia species is not automatically a test for every Babesia species.

At the same time, evidence that a Babesia species exists in ticks or animals in a region does not establish how often that organism causes human illness. Likewise, antibody evidence of previous exposure does not by itself prove active infection.

Types of Babesia Testing

Blood Smear — Giemsa Stain

1. Detects parasites inside red blood cells.
2. Provides direct evidence of parasitemia when organisms are seen.
3. Detection becomes more difficult when parasite levels are very low.

A single negative blood smear does not necessarily exclude babesiosis when clinical suspicion remains high. Examination of multiple smears or additional testing may be appropriate depending on the clinical situation.

PCR — Polymerase Chain Reaction

1. Detects Babesia DNA circulating in the blood.
2. Can detect infection when parasite levels are too low to be easily identified by microscopy.
3. A negative PCR reduces the likelihood of active infection but must still be interpreted in the context of timing, parasite burden, the species targeted by the assay, and the overall clinical picture.

PCR was an important advance in Babesia diagnosis. Persing and colleagues demonstrated that PCR could detect B. microti DNA and identify infection that could be difficult to recognize using conventional microscopy alone.²

However, PCR is not one universal test. Some assays are species-specific, while broader molecular approaches may target multiple species. Clinicians therefore need to know which organisms a particular assay was designed to detect.^1,8

Antibody Testing — IgM and IgG

1. Measures the immune response to Babesia rather than directly detecting the parasite.
2. Can provide evidence of exposure when direct detection tests are negative.
3. Antibodies may remain detectable after infection has cleared, so a positive antibody test does not by itself establish active parasitemia.
4. Antibody assays may also be directed at particular Babesia species.
5. Patients with impaired immune responses may not produce the expected antibody response.

In my practice, antibody testing can provide useful additional information, particularly when patients are evaluated later in the course of illness. I do not interpret antibody results in isolation.

Specialized and Broader Molecular Assays

Some laboratories offer additional molecular or species-specific Babesia testing. Broader molecular assays may also be available in selected settings when an uncommon species is suspected.

These tests can be useful when the epidemiologic history or clinical presentation raises concern that routine species-specific testing may not answer the entire question. However, broader testing does not eliminate every diagnostic limitation, and laboratory findings still need to be interpreted in clinical context.

Why False-Negative Babesia Tests Happen

Several factors can contribute to a negative result despite continued clinical concern:

1. Low parasite burden — Microscopy becomes less sensitive when very few red blood cells are infected.
2. Timing — Parasite burden can change over the course of illness, affecting the likelihood of detection.
3. Species limitations — A test designed for one Babesia species may not necessarily detect every species capable of causing human disease.
4. Geographic mismatch — Travel or exposure outside the region where the most commonly tested species predominates may change which species should be considered.
5. Single-test reliance — Smear, PCR, and antibody testing measure different aspects of infection and have different limitations.
6. Delayed presentation — Patients evaluated later may no longer have the anemia, thrombocytopenia, elevated bilirubin, or other abnormalities often associated with acute babesiosis.
7. Impaired immune response — Immunocompromised patients may have unusual or prolonged infection and may not mount typical antibody responses.

The Hidden Risk: Transfusion-Transmitted Babesiosis

Babesia can also be transmitted through blood transfusion.

This is particularly important because infected donors may have no symptoms while carrying low levels of parasites. Persistent asymptomatic infection therefore has implications beyond the individual patient.

A report from Connecticut described three premature infants who developed Babesia microti infection after receiving blood products traced to a single donor.

Blood-donor screening has advanced substantially since many of the earlier transfusion-associated cases were reported. Nevertheless, transfusion transmission demonstrates an important biological point: people can carry Babesia without having the dramatic symptoms or high parasite levels typically associated with acute babesiosis.

Did You Know?

A negative test may answer a narrower question than patients realize.

A negative blood smear means parasites were not identified in the blood examined. A negative species-specific PCR means DNA from the organism targeted by that assay was not detected. A negative antibody test means the expected antibody response was not detected.

Those results are important—but they are not necessarily interchangeable, and none should be interpreted without knowing what the test was designed to detect.

The Patient Impact of False-Negative Babesia Testing

The consequences of missed infection can be particularly important in patients at higher risk for severe or relapsing babesiosis.

In my own practice, I have also seen patients whose initial Babesia testing was negative but whose later PCR, antibody testing, or repeat evaluation provided additional evidence supporting the diagnosis.

By that point, some had already experienced months of unexplained symptoms.

I have also treated selected patients when laboratory testing remained negative but the overall clinical picture continued to raise substantial concern for Babesia. Some improved with Babesia-directed treatment. That clinical response can be informative, but improvement with treatment alone does not prove that active Babesia infection was present.

Testing remains one part of a broader diagnostic assessment.

Clues It May Be Babesia

Certain clinical patterns can raise my suspicion for Babesia, particularly in a patient with appropriate tick exposure:

• Drenching night sweats
• Fevers or chills
• Profound fatigue or weakness
• Headache or muscle aches
• Anemia or thrombocytopenia during acute illness
• A sensation of air hunger or unexplained breathlessness
• Persistent illness despite treatment directed at Lyme disease alone

None of these findings by itself confirms babesiosis. Air hunger, fatigue, sweats, and other symptoms have many potential causes.

When the overall pattern remains concerning, however, I do not consider a single negative Babesia test the end of the diagnostic evaluation.

Clinical Perspective

No single Babesia test answers every diagnostic question.

Blood smear provides direct visualization of parasites but becomes more difficult when parasitemia is low. PCR can detect lower parasite burdens than microscopy, but the result depends partly on the assay and species being targeted. Antibody testing can provide evidence of exposure but cannot by itself distinguish active from previously cleared infection.

The 2024 Chen review adds another important piece to this picture: persistent and relapsing disease with low-grade parasitemia is documented in the medical literature.¹

The 2024 Cook and Puri paper highlights a different limitation: the diversity of Babesia species and geographic differences in their distribution can matter when selecting and interpreting laboratory testing.⁸

Neither finding means that negative testing should simply be disregarded. A negative result lowers the probability of the infection that the test was capable of detecting. The question is whether the test, timing, and organism targeted were appropriate for the clinical situation.

At the same time, persistent symptoms should not automatically be attributed to persistent Babesia. Lyme disease, another tick-borne infection, post-infectious effects, autonomic dysfunction, medication effects, and unrelated medical conditions may produce overlapping symptoms.

The goal is not to disregard negative testing. It is to understand what a particular negative result can—and cannot—tell us.

Clinical Takeaway

Babesia testing has advanced considerably, but no single test detects every infection under every circumstance.

Low-level parasitemia can make direct detection difficult. Timing and immune status can affect results. And importantly, Babesia is not a single organism: multiple species can cause human disease, while some diagnostic assays target only particular species.

A negative test therefore lowers the likelihood of babesiosis, but its meaning depends on the test used, parasite burden, timing, species targeted, geographic and travel history, immune status, and clinical presentation.

For a patient with Lyme disease who remains ill with otherwise unexplained sweats, fevers, profound fatigue, anemia, thrombocytopenia, air hunger, or other compatible findings, Babesia may remain part of the differential diagnosis even after an initial negative test.

Have you experienced delayed Babesia diagnosis or false-negative testing? Share your experience below.

Frequently Asked Questions

Can a Babesia test be negative even if you have Babesia?

Yes. A negative test lowers the likelihood of babesiosis but does not always exclude it. Blood smear, PCR, and antibody tests measure different aspects of infection and have different limitations. Low parasite burden, timing, species differences, and immune status can affect test results.

Can a Babesia test miss the infection because it tests for the wrong species?

Potentially. Some Babesia tests are designed to detect a particular species. A negative species-specific test therefore does not necessarily exclude every Babesia species capable of infecting humans. Residence, travel history, tick exposure, and the organisms targeted by the laboratory may be important when interpreting the result.

Does a negative Babesia microti PCR rule out every type of Babesia?

No. A species-specific Babesia microti PCR is designed to detect B. microti. Other Babesia species may require different or broader molecular testing. However, uncommon species should be considered according to the patient’s exposure history and clinical circumstances rather than assumed to be present simply because a B. microti test is negative.

What is the most accurate Babesia test?

There is no single best test for every clinical situation. Blood smear can directly demonstrate parasites and measure parasitemia. PCR is particularly useful when parasite levels are low, although clinicians should know which species the assay detects. Antibody testing provides evidence of an immune response but cannot by itself establish whether parasites remain present.

Can Babesia persist with low parasite levels?

Yes. Persistent, intermittent, and low-level Babesia microti infection has been documented in the medical literature. Persistent and relapsing babesiosis is particularly important in immunocompromised patients, although prolonged infection has also been reported in people without recognized immunosuppression.

Why does travel history matter when testing for Babesia?

Babesia species vary geographically. The species responsible for most recognized babesiosis in one region may not be the same species encountered elsewhere. Knowing where a patient lives and has traveled can therefore help determine whether the testing performed adequately addresses the relevant exposure.

Related Articles

Learn more about Babesia symptoms, diagnosis, treatment, and related tick-borne infections:

1. Babesia Symptoms: Why This Tick-Borne Infection Is Often Missed
2. Babesia and Lyme Disease: Why Coinfection Makes Recovery Harder
3. Babesia Symptoms: Night Sweats, Air Hunger, and Treatment
4. Congenital Babesiosis: Can Babesia Pass to a Baby?
5. Can Blood Transfusions Transmit Babesia to Premature Infants?

References

1. Chen F, Fu S, Jiang JF, et al. Persistent human babesiosis with low-grade parasitemia, challenges for clinical diagnosis and management. Heliyon. 2024;10(22):e39960. doi:10.1016/j.heliyon.2024.e39960. PMID: 39634383.
2. Persing DH, Mathiesen D, Marshall WF, et al. Detection of Babesia microti by polymerase chain reaction. J Clin Microbiol. 1992;30(8):2097-2103. doi:10.1128/JCM.30.8.2097-2103.1992. PMID: 1500517.
3. Krause PJ, Spielman A, Telford SR III, et al. Persistent parasitemia after acute babesiosis. N Engl J Med. 1998;339(3):160-165. doi:10.1056/NEJM199807163390304. PMID: 9664092.
4. Krause PJ, Telford SR III, Spielman A, et al. Concurrent Lyme disease and babesiosis: evidence for increased severity and duration of illness. JAMA. 1996;275(21):1657-1660. PMID: 8637139.
5. Krause PJ. Babesiosis diagnosis and treatment. Vector Borne Zoonotic Dis. 2003;3(1):45-51. doi:10.1089/153036603765627451. PMID: 12804380.
6. Kjemtrup AM, Conrad PA. Human babesiosis: an emerging tick-borne disease. Int J Parasitol. 2000;30(12-13):1323-1337. doi:10.1016/S0020-7519(00)00137-5. PMID: 11113258.
7. Vannier E, Hunfeld KP, Smith RP, Krause PJ. Management of human babesiosis – approaches and perspectives. Expert Rev Anti Infect Ther. 2025;23(9):739-752. doi:10.1080/14787210.2025.2526843. PMID: 40596759.
8. Cook MJ, Puri BK. Babesiosis: analysis of the evidence for infections in the United Kingdom. Int J Gen Med. 2024;17:4627-4631. doi:10.2147/IJGM.S485759. PMID: 39429956.

This article is intended for educational purposes and is not a substitute for individual medical advice, diagnosis, or treatment.

Dr. Daniel Cameron, MD, MPH
Lyme disease clinician with over 30 years of experience and past president of ILADS.

Symptoms • Testing • Coinfections • Recovery • Pediatric • Prevention